Injeq Oy Shares Have Been Transferred to Finnish Book-Entry Securities System – Instructions for Shareholders

Injeq Oy Annual General Meeting resolved on 26th May 2021 to transfer the shares of the company into the Finnish book-entry securities system. Appropriate instructions were sent to all shareholders by email in June 2021 and on 16th September 2021 the shares were incorporated in the book-entry system. In case you have not received the said instructions, or your shares have not been transferred for some other reason, we ask you to contact ir@injeq.com for instructions.

The transfer to the Finnish book-entry securities system means that the maintenance of the Company’s shareholder register has been transferred to Euroclear Finland Ltd. A shareholder may not use shareholder rights in the Company before the shareholder has been registered in the shareholders’ register maintained in Euroclear Finland Ltd. The shareholding of each shareholder will be entered into the shareholder’s personal book-entry account in connection with the transfer to the Finnish book-entry securities system.

If your place of residence is outside Finland and your foreign bank can’t take into custody unlisted Finnish securities, and you are unwilling or unable to open a book-entry account in Finland, you do not need to do anything at this point – your ownership will remain unchanged. If the Company’s securities are listed in the future, this should allow your bank to then take custody of your newly listed securities.

For any questions or to update your contact information for future use please do not hesitate to contact us at ir@injeq.com.

Board of Directors of Injeq Oy

FDA grants breakthrough device designation for Injeq IQ-Tip® smart needle

Injeq is happy to announce that Injeq IQ-Tip device with its indications for use meet the criteria and have been […]
Read more »

Breakthrough Device designation granted by FDA

Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »

Injeq grows – new distributor in Hong Kong

Injeq visited Hong Kong in May and met with local hospital management there. The interest towards Injeq IQ-Tip® system convinced […]
Read more »

Large multicenter trial of pediatric hemato-oncology patients sponsored by Injeq

A clinical investigation conducted in all five Finnish university hospitals and sponsored by Injeq has begun in May. A peer-reviewed […]
Read more »

Two more weeks to go!

There are two weeks left in Injeq’s share issue. Read the promising news and invest: Funding: Injeq Oyj (invesdor.com)   […]
Read more »

Injeq IQ-Tip®: Benefits for healthcare and society

Post-dural puncturel headache after lumbar puncture is a difficult post-procedure complication caused by cerebrospinal fluid seeping through the lumbar puncture […]
Read more »